Granzyme B–Mediated Activation-Induced Death of CD4+ T Cells Inhibits Murine Acute Graft-versus-Host Disease
Open Access
- 1 November 2015
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 195 (9), 4514-4523
- https://doi.org/10.4049/jimmunol.1500668
Abstract
Granzyme B (GzmB) has previously been shown to be critical for CD8+ T cell–mediated graft-versus-host disease (GVHD) but dispensable for GVHD mediated by CD4+ T cells. However, previous studies used high doses of CD4+ T cells in MHC-mismatched models that caused rapid and lethal GVHD. Because of the hyperacute lethality, it is possible that the role of GzmB was concealed by the system. Therefore, in this study, we have titrated down the T cell dose to precisely determine the contribution of GzmB in GVHD mediated by CD4+CD25– T cells. Surprisingly, we have found that GzmB−/−CD4+CD25– T cells cause more severe GVHD compared with wild-type CD4+CD25– T cells in both MHC-matched and mismatched models. Mechanistic analyses reveal that although GzmB does not affect donor T cell engraftment, proliferation or tissue-specific migration, GzmB−/− CD4+CD25– T cells exhibit significantly enhanced expansion because of GzmB-mediated activation-induced cell death of wild-type CD4+CD25– T cells. As a result of enhanced expansion, GzmB−/− T cells produced higher amounts of proinflammatory cytokines (e.g., TNF-α and IFN-γ) that may contribute to the exacerbated GVHD. These results reveal that GzmB diminishes the ability of CD4+ T cells to cause acute GVHD, which contradicts its established role in CD8+ T cells. The differential roles suggest that targeting GzmB in selected T cell subsets may provide a strategy to control GVHD.Keywords
This publication has 32 references indexed in Scilit:
- Advances in graft-versus-host disease biology and therapyNature Reviews Immunology, 2012
- Combination of Intra-Bone Marrow–Bone Marrow Transplantation and Subcutaneous Donor Splenocyte Injection Diminishes Risk of Graft-Versus-Host Disease and Enhances Survival RateStem Cells and Development, 2011
- Granzyme B is not required for regulatory T cell–mediated suppression of graft-versus-host diseaseBlood, 2010
- Noncytotoxic Lytic Granule–Mediated CD8 + T Cell Inhibition of HSV-1 Reactivation from Neuronal LatencyScience, 2008
- Acquisition of Murine NK Cell Cytotoxicity Requires the Translation of a Pre-existing Pool of Granzyme B and Perforin mRNAsImmunity, 2007
- Perforin and Granzymes Have Distinct Roles in Defensive Immunity and ImmunopathologyImmunity, 2006
- Hematopoietic Stem-Cell TransplantationNew England Journal of Medicine, 2006
- The ABCs of granule-mediated cytotoxicity: new weapons in the arsenalNature Reviews Immunology, 2003
- Lymphocyte-Mediated CytotoxicityAnnual Review of Immunology, 2002
- Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient miceNature, 1994